| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,440 | 1,450 | 23.06. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | IKONISYS: Update on the suspension of trading of ALIKO shares on Euronext Growth Paris and postponement of the publication of the 2025 annual financial report | - | Euronext | ||
| 15.06. | XFRA 9W8: AUSSETZUNG/SUSPENSION | 89 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 0,5... ► Artikel lesen | |
| IKONISYS Aktie jetzt für 0€ handeln | |||||
| 25.05. | Aliko Scientific gründet Joint Venture in Brasilien zur Herstellung von FISH-Sonden | 1 | Investing.com Deutsch | ||
| 25.05. | Aliko Scientific signs Brazil JV to manufacture FISH probes | 1 | Investing.com | ||
| 25.05. | Aliko Scientific SA: Aliko Scientific Signs Memorandum of Understanding with BioBrasil for Brazilian FISH Probe Manufacturing Joint Venture | 456 | Business Wire | Aliko Scientific signs Brazilian JV with BioBrasil to manufacture proprietary FISH probes for global diagnostic markets New "instrument probes" model aims to create recurring revenues and... ► Artikel lesen | |
| 19.05. | Aliko Scientific SA: Aliko Scientific Announces Award of Major Five-Year Public Tender at Federico II University Hospital | 324 | Business Wire | Execution of the long-term strategy focused on recurring revenue and developing opportunities for sustainable growth Contract with a potential total value of approximately €620,000, over... ► Artikel lesen | |
| 11.05. | Aliko Scientific SA: Aliko Scientific Signs Strategic Memorandum of Understanding with Cellay Inc. and Secures First Commercial Customer in Arizona | 425 | Business Wire | Regulatory News:
Aliko Scientific SA ("Aliko Scientific" or the "Company") (Euronext Growth Paris: ALIKO), an industrial and financial holding company focused on advanced oncology diagnostics... ► Artikel lesen | |
| 10.03. | Aliko Scientific signs Italy distribution deal for bladder test | 1 | Investing.com | ||
| 10.03. | Ikonisys: Hospitex International Signs Strategic Distribution Agreement With Naturneed for Urine24, Strengthening Its Commercial Footprint in the Italian Urology Diagnostics Market | 399 | Business Wire | Regulatory News:
Hospitex International, part of Aliko Scientific Group (Ticker: ALIKO), announces the signing of a strategic distribution agreement with Naturneed for the commercialization in... ► Artikel lesen | |
| 24.02. | Aliko Scientific: Outstanding Success at WHX Labs Dubai With 172 Commercial Leads and Strong Global Interest in the New Integrated Oncology Diagnostics Platform | 399 | Business Wire | Regulatory News:
Aliko Scientific SA (Ticker: ALIKO) previously Ikonisys SA, announces a highly successful first market appearance at WHX Labs Dubai, the world's largest medical trade exhibition... ► Artikel lesen | |
| 18.02. | Aliko Scientific: Francesco Trisolini Appointed as New Group CEO to Pursue the Implementation of the Approved Industrial Plan | 442 | Business Wire | Regulatory News:
Aliko Scientific SA (Ikonisys SA Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution... ► Artikel lesen | |
| 19.12.25 | Ikonisys SA: Ikonisys finalized a Capital Increase and Debt Conversion of EUR 2.72 million with strategic investment from Avantgarde Srl and Alberto Previtali | 490 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 04.12.25 | Ikonisys SA: Ikonisys: Cytofast Auto: The First Fully Automatic Universal Monolayer Cytology Processor Is Born | 382 | Business Wire | Regulatory News:
Hospitex international, the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices... ► Artikel lesen | |
| 24.11.25 | Ikonisys SA: Ikonisys: Hospitex Initiates International Dialogues for Pilot Projects in Oncology Diagnostics Following ADB Delegation Visit | 497 | Business Wire | Regulatory News:
Hospitex, the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices, announces... ► Artikel lesen | |
| 07.10.25 | Ikonisys SA: Hospitex Wins Public Tender at Policlinico di Bari for Cytofast Cytology Systems | 355 | Business Wire | Regulatory News:
Hospitex,the fully owned Italian subsidiary of Aliko Scientific (Ikonisys SA, Euronext Growth Paris: ALIKO) and leader in the production of cytology medical devices, has been... ► Artikel lesen | |
| 30.09.25 | XFRA 9W8: WIEDERAUFNAHME/RESUMPTION | 247 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 01.07.25 | Ikonisys SA: Suspension of Trading of Shares on Euronext Growth Paris Until the Publication of the 2024 Annual Report | 425 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 01.07.25 | XFRA 9W8: AUSSETZUNG/SUSPENSION | 450 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 2 9W8... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 39,900 | +0,91 % | DAX-Check LIVE: Auto1, BMW, Fresenius, Munich Re, Vonovia im Fokus | Der deutsche Aktienmarkt hat den Dienstag nur mit einem Mini-Plus beendet. Der DAX, der am Morgen noch über 25.100 Punkten notiert hatte, schloss am Ende lediglich 0,07 Prozent fester bei 24.910 Zählern.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,550 | +0,73 % | 3 Charts in 3x33 Sekunden - Heute mit Intel, Dow Jones und FMC | 3 Charts in 3x33 Sekunden - Heute mit Intel, Dow Jones und FM ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,520 | +0,06 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 66,83 | -0,55 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BETA BIONICS | 13,670 | -0,22 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| HEARTSCIENCES | 2,750 | +55,37 % | Fortitude Mining Holdings, Inc. and HeartSciences Inc. Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets | FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences")... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 26,940 | -1,75 % | DAX-Check LIVE: Brenntag, Carl Zeiss Meditec, DWS, Infineon, RWE, Vonovia im Fokus | Der deutsche Aktienmarkt hat den Wochenauftakt mit Gewinnen beendet. Der DAX schloss 0,6 Prozent fester bei 25.139 Punkten und verteidigte damit erneut die psychologisch wichtige Marke von 25.000 Zählern.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,645 | +1,67 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,600 | -2,18 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 58,02 | +4,69 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 34,450 | +1,80 % | Heartflow, Inc. - 8-K, Current Report | ||
| GERRESHEIMER | 27,400 | +5,79 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
22.06.2026 / 11:08 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 26,610 | +1,26 % | Truist raises Progyny stock price target to $33 on growth outlook | ||
| BILLIONTOONE | 104,30 | +3,55 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| TALKSPACE | 5,200 | -0,19 % | NSE - Talkspace, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities |